Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE.

Cancer Res. 2003 Jul 1;63(13):3695-700.

PMID:
12839961
[PubMed - indexed for MEDLINE]
Free Article
2.

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other.

Hellstrom I, Hellstrom KE.

Adv Exp Med Biol. 2008;622:15-21. doi: 10.1007/978-0-387-68969-2_2. Review.

PMID:
18546615
[PubMed - indexed for MEDLINE]
3.

Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis.

Wu L, Dai ZY, Qian YH, Shi Y, Liu FJ, Yang C.

Int J Gynecol Cancer. 2012 Sep;22(7):1106-12. doi: 10.1097/IGC.0b013e318263efa2. Review.

PMID:
22854652
[PubMed - indexed for MEDLINE]
4.

New tumor markers: CA125 and beyond.

Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K.

Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:274-81. Review.

PMID:
16343244
[PubMed - indexed for MEDLINE]
5.

Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.

Lin J, Qin J, Sangvatanakul V.

Eur J Obstet Gynecol Reprod Biol. 2013 Mar;167(1):81-5. doi: 10.1016/j.ejogrb.2012.10.036. Epub 2012 Dec 7. Review.

PMID:
23228410
[PubMed - indexed for MEDLINE]
6.

HE4 as a biomarker for ovarian and endometrial cancer management.

Li J, Dowdy S, Tipton T, Podratz K, Lu WG, Xie X, Jiang SW.

Expert Rev Mol Diagn. 2009 Sep;9(6):555-66. doi: 10.1586/erm.09.39. Review.

PMID:
19732003
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prevention and early detection of ovarian cancer: mission impossible?

Bast RC Jr, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, Lu K, Lu Z, Badgwell D, Mills GB, Skates S, Zhang Z, Chan D, Lokshin A, Yu Y.

Recent Results Cancer Res. 2007;174:91-100. Review.

PMID:
17302189
[PubMed - indexed for MEDLINE]
8.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
[PubMed - indexed for MEDLINE]
9.

Discovery and application of protein biomarkers for ovarian cancer.

Gagnon A, Ye B.

Curr Opin Obstet Gynecol. 2008 Feb;20(1):9-13. doi: 10.1097/GCO.0b013e3282f226a5. Review.

PMID:
18196999
[PubMed - indexed for MEDLINE]
10.

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

Nossov V, Amneus M, Su F, Lang J, Janco JM, Reddy ST, Farias-Eisner R.

Am J Obstet Gynecol. 2008 Sep;199(3):215-23. doi: 10.1016/j.ajog.2008.04.009. Epub 2008 May 12. Review.

PMID:
18468571
[PubMed - indexed for MEDLINE]
11.

Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker.

Speeckaert MM, Speeckaert R, Delanghe JR.

Adv Clin Chem. 2013;59:1-21. Review.

PMID:
23461131
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk